Ad is loading...
RENB
Price
$0.50
Change
-$0.08 (-13.79%)
Updated
Nov 15 closing price
TNGX
Price
$3.85
Change
-$0.07 (-1.79%)
Updated
Nov 15 closing price
133 days until earnings call
Ad is loading...

RENB vs TNGX

Header iconRENB vs TNGX Comparison
Open Charts RENB vs TNGXBanner chart's image
Renovaro
Price$0.50
Change-$0.08 (-13.79%)
Volume$338.81K
CapitalizationN/A
Tango Therapeutics
Price$3.85
Change-$0.07 (-1.79%)
Volume$3.63M
CapitalizationN/A
RENB vs TNGX Comparison Chart
Loading...
RENB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RENB vs. TNGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RENB is a StrongSell and TNGX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (RENB: $0.50 vs. TNGX: $3.85)
Brand notoriety: RENB and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RENB: 67% vs. TNGX: 182%
Market capitalization -- RENB: $80.62M vs. TNGX: $413.56M
RENB [@Biotechnology] is valued at $80.62M. TNGX’s [@Biotechnology] market capitalization is $413.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RENB’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • RENB’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, TNGX is a better buy in the long-term than RENB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENB’s TA Score shows that 2 TA indicator(s) are bullish while TNGX’s TA Score has 4 bullish TA indicator(s).

  • RENB’s TA Score: 2 bullish, 8 bearish.
  • TNGX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than RENB.

Price Growth

RENB (@Biotechnology) experienced а -21.37% price change this week, while TNGX (@Biotechnology) price change was +30.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

RENB is expected to report earnings on May 12, 2023.

TNGX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($414M) has a higher market cap than RENB($80.6M). TNGX YTD gains are higher at: -61.111 vs. RENB (-84.274). RENB has higher annual earnings (EBITDA): -52.79M vs. TNGX (-129.96M). TNGX has more cash in the bank: 322M vs. RENB (313K). RENB has less debt than TNGX: RENB (8.57M) vs TNGX (37.8M). TNGX has higher revenues than RENB: TNGX (42.5M) vs RENB (0).
RENBTNGXRENB / TNGX
Capitalization80.6M414M19%
EBITDA-52.79M-129.96M41%
Gain YTD-84.274-61.111138%
P/E RatioN/AN/A-
Revenue042.5M-
Total Cash313K322M0%
Total Debt8.57M37.8M23%
FUNDAMENTALS RATINGS
RENB: Fundamental Ratings
RENB
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RENBTNGX
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
RENB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCCPX21.87-0.15
-0.68%
BlackRock Sustainable Balanced Inv C
RYENX249.45-1.94
-0.77%
Rydex Energy A
CBLSX13.99-0.11
-0.78%
Allspring Large Cap Value Inst
FCUPX19.66-0.25
-1.26%
NYLI PineStone U.S. Equity Class P
PRGSX66.17-0.97
-1.44%
T. Rowe Price Global Stock

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-14.60%
VRCA - RENB
37%
Loosely correlated
-3.45%
DTIL - RENB
36%
Loosely correlated
-1.04%
TNGX - RENB
34%
Loosely correlated
-1.79%
AAVXF - RENB
26%
Poorly correlated
N/A
QSI - RENB
26%
Poorly correlated
-5.77%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-1.79%
AXON - TNGX
41%
Loosely correlated
-0.86%
MDGL - TNGX
39%
Loosely correlated
-4.66%
BNTC - TNGX
36%
Loosely correlated
+2.69%
ORMP - TNGX
36%
Loosely correlated
-4.50%
VERA - TNGX
35%
Loosely correlated
-5.59%
More